LSBCF (LakeShore Biopharma Co) Marketable Securities: $0.00 Mil (As of Mar. 2025)


What is LakeShore Biopharma Co Marketable Securities?

LakeShore Biopharma Co LSBCF Marketable Securities is $0.00 Mil as of Mar. 2025.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. LakeShore Biopharma Co's Marketable Securities for the quarter that ended in Mar. 2025 was $0.00 Mil.

LakeShore Biopharma Co  (OTCPK:LSBCF) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

LakeShore Biopharma Co Marketable Securities Related Terms

LakeShore Biopharma Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Marketable Securities Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Marketable Securities
0.00 0.00 0.00 0.00 0.00

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Marketable Securities Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

LakeShore Biopharma Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $0.00 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Marketable Securities of $0.00 Mil as of Mar. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Marketable Securities too high?
LakeShore Biopharma Co's current Marketable Securities is $0.00 Mil.
How does LakeShore Biopharma Co's Marketable Securities compare to ACUT and PPCB?
LakeShore Biopharma Co's Marketable Securities of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Marketable Securities is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Marketable Securities of $0.00 Mil. The current Marketable Securities is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Marketable Securities is $0.00 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.